Mumps in adults is caused by the same virus that causes it in children: a paramyxovirus that spreads through saliva and respiratory droplets. But the reason mumps still shows up in adults, even vaccinated ones, has more to do with waning immunity than the virus itself. Understanding both the pathogen and the vulnerability gap explains why adults in their 20s and 30s are now the most common age group in U.S. outbreaks.
The Virus Behind Mumps
Mumps is caused by a member of the Rubulavirus family. After entering the body through the mouth or nose, the virus replicates in the upper respiratory tract before spreading to other tissues, particularly the salivary glands. That’s what produces the hallmark swelling along the jawline, called parotitis, that most people associate with the disease.
The virus passes from person to person through direct contact with saliva or respiratory droplets. Sharing drinks, kissing, coughing in close quarters, or touching surfaces contaminated with saliva can all spread it. This makes any setting with prolonged, close contact a prime environment for transmission.
Why Adults Are Still Getting Mumps
Two doses of the MMR vaccine are about 86% effective at preventing mumps, and one dose is about 72% effective. That’s solid protection, but it leaves a gap, and that gap widens over time. Immunity from childhood vaccination doesn’t hold steady the way it does for measles or rubella. Research published in the Proceedings of the National Academy of Sciences found that people who were furthest from their last MMR dose, generally more than 15 years out, had the lowest levels of protective antibodies against mumps.
The decline is significant. In that same study, 10% of participants had no detectable memory B cells for mumps at all, meaning their immune systems had essentially lost the blueprint for fighting the virus. The body’s circulating mumps-specific immune cells were 5 to 10 times lower than those for measles and rubella, which helps explain why mumps breaks through vaccination far more often than those other diseases.
There’s also a mismatch problem. The vaccine uses one genetic strain of mumps (genotype A), but the strain circulating most widely in recent outbreaks is genotype G. Neutralizing antibody levels against the wild-type strain were six-fold lower than levels against the vaccine strain. So even when antibodies are present, they’re less effective against the virus people actually encounter.
During mumps outbreaks in France in 2013, the odds of getting mumps increased by 10% for every year that passed after the second MMR dose. A case-control study on a U.S. college campus found the same pattern: students who developed mumps were more likely to have received their second dose 10 or more years earlier.
Where Adult Outbreaks Happen
Most recent U.S. outbreaks have centered on environments where people spend a lot of time in close contact. College campuses, correctional facilities, and close-knit communities are the most common settings. In 2006, a multi-state outbreak infected more than 6,500 people, mostly college-aged students across the Midwest. In 2016 and 2017, two large outbreaks in Iowa and Illinois each involved several hundred university students.
The pattern makes sense: dorms, shared dining halls, and crowded social spaces create exactly the kind of prolonged exposure the virus needs to spread. Young adults in these settings are typically 15 to 20 years past their last vaccination, right in the window where immunity is at its weakest.
Symptoms in Adults
When adults get mumps, the illness often starts with a few days of fatigue, headache, muscle aches, low appetite, and mild fever. Swelling of the salivary glands, usually on one or both sides of the face just below and in front of the ears, follows. The swelling typically lasts at least two days and can make chewing or swallowing painful. Some adults have very mild symptoms or none at all, which makes the virus harder to contain because people don’t realize they’re contagious.
Complications Are More Common in Adults
This is the part that matters most for adults searching this topic. Certain complications of mumps occur more frequently in adults than in children, and some can be serious.
The most common adult complication is orchitis, inflammation of one or both testicles. It occurs in roughly 30% of unvaccinated post-pubertal males who get mumps, and about 6% of vaccinated ones. Orchitis is painful and can occasionally affect fertility, though complete sterility from mumps is rare. In adolescent and adult women, inflammation of the ovaries (oophoritis) and breast tissue (mastitis) have each been reported in fewer than 1% of cases in the vaccine era.
Pancreatitis, hearing loss, meningitis, and encephalitis have all been reported in under 1% of cases during recent U.S. outbreaks. These are uncommon, but they’re the reason mumps in adults is taken more seriously than a childhood case of swollen cheeks.
How Mumps Is Diagnosed
If you develop parotitis or other symptoms consistent with mumps, your doctor will likely order a swab from the inside of your cheek (a buccal swab). The gold standard is a molecular test called RT-PCR, which detects the virus’s genetic material and is the most reliable way to confirm infection. Ideally the swab is collected within three days of symptom onset. If more than three days have passed, a blood draw to check for mumps-specific antibodies is usually added.
One important nuance: a negative test doesn’t always rule out mumps. In vaccinated people, the immune system may partially suppress the virus, making it harder to detect on a swab. If symptoms fit, doctors may still treat the case as probable mumps even with a negative initial result.
Who Is Most at Risk
Several groups of adults face higher risk:
- Young adults vaccinated in childhood: Those who are 15 or more years past their second MMR dose have measurably lower protection and account for the bulk of outbreak cases.
- Adults born before 1957: Generally considered immune because they likely had natural mumps infection. But adults born between 1957 and the late 1980s may have received only one dose of MMR, which provides lower protection.
- Unvaccinated adults: Anyone who never received the MMR vaccine has no baseline immunity and faces the highest risk of both infection and complications.
- People in high-density settings: College students, military personnel, inmates, and healthcare workers are more likely to encounter the virus simply because of how much close contact their environments involve.
Prevention for Adults
If you’re unsure of your vaccination status, a blood test can check for mumps antibodies, though having antibodies doesn’t guarantee full protection. The standard adult recommendation is two documented doses of MMR. During active outbreaks in high-risk settings, public health authorities sometimes recommend a third dose to boost waning immunity.
Beyond vaccination, the practical prevention measures are the same ones that limit any respiratory virus: avoiding shared utensils and drinks, washing hands frequently, and staying away from others if you develop symptoms. If you do get mumps, you’re generally considered contagious from a few days before salivary gland swelling begins through about five days after it starts, so isolation during that window helps prevent further spread.